Cargando…

Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment

INTRODUCTION: Glioma stem cells (GSCs) play an important role in glioma recurrence and chemo‐radiotherapy (CRT) resistance. Currently, there is a lack of efficient treatment approaches targeting GSCs. This study aimed to explore the potential personalized treatment of patients with GSC‐enriched glio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bo, Zhou, Xiaoxi, Yang, Liting, Zhou, Hongshu, Meng, Ming, Wu, Hao, Liu, Zhixiong, Zhang, Liyang, Li, Chuntao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627385/ https://www.ncbi.nlm.nih.gov/pubmed/36070228 http://dx.doi.org/10.1111/cns.13956

Ejemplares similares

The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment
por: Zhou, Hongshu, et al.
Publicado: (2022)

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response
por: Zhou, Hongshu, et al.
Publicado: (2023)

Comprehensive Analysis of Endoplasmic Reticulum Stress in Intracranial Aneurysm
por: Chen, Bo, et al.
Publicado: (2022)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

Predicting the prognosis of glioma by pyroptosis‐related signature
por: Chao, Bo, et al.
Publicado: (2021)

Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized medicine
por: Chen, Bo, et al.
Publicado: (2023)

Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
por: Wu, Yangyang, et al.
Publicado: (2023)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

HMOX1 promotes lung adenocarcinoma metastasis by affecting macrophages and mitochondrion complexes
por: Chen, Bo, et al.
Publicado: (2022)

Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021)

NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
por: Lucena-Cacace, Antonio, et al.
Publicado: (2017)

A Pyroptosis-Related Gene Signature Associated with Prognosis and Tumor Immune Microenvironment in Gliomas
por: Zhou, Zunjie, et al.
Publicado: (2022)

CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
por: Cheng, Quan, et al.
Publicado: (2021)

The molecular feature of macrophages in tumor immune microenvironment of glioma patients
por: Zhang, Hao, et al.
Publicado: (2021)

Identification of a gene signature associated with radiotherapy and prognosis in gliomas
por: Li, Shu, et al.
Publicado: (2017)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
por: Wang, Weichen, et al.
Publicado: (2022)

Tumor Treating Fields in the Management of Patients with Malignant Gliomas
por: Ghiaseddin, Ashley P., et al.
Publicado: (2020)

Outcome of Endoscopic Transsphenoidal Surgery for Recurrent or Residual Pituitary Adenomas and Comparison to Non-Recurrent or Residual Cohort by Propensity Score Analysis
por: Gong, Xuan, et al.
Publicado: (2022)

A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma
por: Xu, Shengchao, et al.
Publicado: (2020)

The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas
por: Song, Jingjing, et al.
Publicado: (2023)

Applications of organoid technology to brain tumors
por: Wen, Jie, et al.
Publicado: (2023)

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer
por: Zhou, Xiaohan, et al.
Publicado: (2023)

Evaluation of a tumor electric field treatment system in a rat model of glioma
por: Wu, Hao, et al.
Publicado: (2020)

Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
por: Zhou, Zhengui, et al.
Publicado: (2018)

Biological activity of tumor-treating fields in preclinical glioma models
por: Silginer, Manuela, et al.
Publicado: (2017)

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020)

Alarm Signal S100-Related Signature Is Correlated with Tumor Microenvironment and Predicts Prognosis in Glioma
por: Wang, Lin-jian, et al.
Publicado: (2022)

Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma
por: Xiao, Zheng, et al.
Publicado: (2023)

Identification of a mesenchymal-related signature associated with clinical prognosis in glioma
por: Zhang, Zhengwei, et al.
Publicado: (2021)

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields
por: Liu, Shiyu, et al.
Publicado: (2021)

A RADIATION ONCOLOGIST’S EXPERIENCE TREATING MALIGNANT GLIOMA WITH TUMOR TREATING FIELDS IN CANADA
por: Roberge, David, et al.
Publicado: (2023)

A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma
por: Chen, Jia, et al.
Publicado: (2022)

Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients
por: Hu, Yan, et al.
Publicado: (2021)

SDPS-28 THE STUDY OF AN ANOIKIS-RELATED SIGNATURE TO PREDICT GLIOMA PROGNOSIS AND IMMUNE INFILTRATION
por: Zhang, Dongdong, et al.
Publicado: (2023)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma
por: Liu, Liang, et al.
Publicado: (2018)

p38γ overexpression in gliomas and its role in proliferation and apoptosis
por: Yang, Kui, et al.
Publicado: (2013)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
por: Zhang, Nan, et al.
Publicado: (2021)

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
por: Crawford, John, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sb7a577fto1nqf4j5b92ebj5gm